Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor
about
Differential effects of dopamine-directed treatments on cognitionTor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury.Deficient Purposeful Use of Forepaws in Female Mice Modelling Rett Syndrome.Mitochondrial Dysfunction in the Pathogenesis of Rett Syndrome: Implications for Mitochondria-Targeted Therapies.Stem Cell Technology for (Epi)genetic Brain Disorders.
P2860
Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Improvement of the Rett syndro ...... a dopa-decarboxylase inhibitor
@ast
Improvement of the Rett syndro ...... a dopa-decarboxylase inhibitor
@en
type
label
Improvement of the Rett syndro ...... a dopa-decarboxylase inhibitor
@ast
Improvement of the Rett syndro ...... a dopa-decarboxylase inhibitor
@en
prefLabel
Improvement of the Rett syndro ...... a dopa-decarboxylase inhibitor
@ast
Improvement of the Rett syndro ...... a dopa-decarboxylase inhibitor
@en
P2093
P2860
P50
P356
P1476
Improvement of the Rett syndro ...... a dopa-decarboxylase inhibitor
@en
P2093
Dori Huertas
Karolina Szczesna
Marta Molero-Luis
Marta Soler
Mauricio A Saez
Olga de la Caridad
Rafael Artuch-Iriberri
P2860
P2888
P304
P356
10.1038/NPP.2014.136
P407
P577
2014-06-11T00:00:00Z
P5875
P6179
1009781118